Inhibition of lncRNA KCNQ1OT1 Improves Apoptosis and Chemotherapy Drug Response in Small Cell Lung Cancer by TGF-β1 Mediated Epithelial-to-Mesenchymal Transition

다국어 초록 (Multilingual Abstract)

Purpose Drug resistance is one of the main causes of chemotherapy failure in patients with small cell lung cancer (SCLC), and extensive biological studies into chemotherapy drug resistance are required.
Materials and Methods In this study, we performed lncRNA microarray, in vitro functional assays, in vivo models and cDNA microarray to evaluate the impact of lncRNA in SCLC chemoresistance.
Results The results showed that KCNQ1OT1 expression was upregulated in SCLC tissues and was a poor prognostic factor for patients with SCLC. Knockdown of KCNQ1OT1 inhibited cell proliferation, migration, chemoresistance and promoted apoptosis of SCLC cells. Mechanistic investigation showed that KCNQ1OT1 can activate transforming growth factor-β1 mediated epithelial-to-mesenchymal transition in SCLC cells.
Conclusion Taken together, our study revealed the role of KCNQ1OT1 in the progression and chemoresistance of SCLC, and suggested KCNQ1OT1 as a potential diagnostic and prognostic biomarker in SCLC clinical management.

참고문헌 (Reference)

1 Li Y, "lncRNA KCNQ1OT1enhances the chemoresistance of oxaliplatin in colon cancer by targeting the miR-34a/ATG4B pathway" 12 : 2649-2660, 2019

2 Rouhrazi H, "Zoledronic acid overcomes chemoresistance by sensitizing cancer stem cells to apoptosis" 93 : 77-88, 2018

3 Sabari JK, "Unravelling the biology of SCLC : implications for therapy" 14 : 549-561, 2017

4 Slack FJ, "The role of non-coding RNAs in oncology" 179 : 1033-1055, 2019

5 Li Z, "The LINC01138drives malignancies via activating arginine methyltransferase 5 in hepatocellular carcinoma" 9 : 1572-, 2018

6 Du B, "Targeting epithelial-mesenchymal transition(EMT)to overcome drug resistance in cancer" 21 : 965-, 2016

7 Mendell JT, "Targeting a long noncoding RNA in breast cancer" 374 : 2287-2289, 2016

8 Xu J, "TGF-beta-induced epithelial to mesenchymal transition" 19 : 156-172, 2009

9 Gaspar LE, "Small-cell lung cancer : prognostic factors and changing treatment over 15 years" 13 : 115-122, 2012

10 Sun X, "Overexpression of long non-coding RNA KCNQ1OT1 is related to good prognosis via inhibiting cell proliferation in non-small cell lung cancer" 9 : 523-531, 2018

11 Zhu L, "M2 macrophages induce EMT through the TGF-beta/Smad2 signaling pathway" 41 : 960-968, 2017

12 Fang S, "Long noncoding RNA-HOTAIR affects chemoresistance by regulating HOXA1 methylation in small cell lung cancer cells" 96 : 60-68, 2016

13 Zhuo W, "Long noncoding RNA GMAN, up-regulated in gastric cancer tissues, is associated with metastasis in patients and promotes translation of ephrin A1 by competitively binding GMAN-AS" 156 : 676-691, 2019

14 Hu H, "Long non-coding RNA KCNQ1OT1 modulates oxaliplatin resistance in hepatocellular carcinoma through miR-7-5p/ABCC1 axis" 503 : 2400-2406, 2018

15 Sun Y, "Long non-coding RNA HOTTIP promotes BCL-2 expression and induces chemoresistance in small cell lung cancer by sponging miR-216a" 9 : 85-, 2018

16 Zheng L, "LncRNA KCNQ1OT1 is overexpressed in non-small cell lung cancer and its expression level is related to clinicopathology" 23 : 6944-6950, 2019

17 Xian D, "LncRNA KCNQ1OT1 enhanced the methotrexate resistance of colorectal cancer cells by regulating miR760/PPP1R1B via the cAMP signalling pathway" 23 : 3808-3823, 2019

18 Zeng F, "Linc00173 promotes chemoresistance and progression of small cell lung cancer by sponging miR-218 to regulate Etk expression" 39 : 293-307, 2020

19 Liu H, "KCNQ1OT1 promotes ovarian cancer progression via modulating MIR-142-5p/CAPN10 axis" 8 : e1077-, 2020

20 Guo B, "KCNQ1OT1 promotes melanoma growth and metastasis" 10 : 632-644, 2018

21 Wang J, "KCNQ1OT1 aggravates cell proliferation and migration in bladder cancer through modulating miR-145-5p/PCBP2 axis" 19 : 325-, 2019

22 Lozano R, "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010 : a systematic analysis for the Global Burden of Disease Study 2010" 380 : 2095-2128, 2012

23 Park JH, "Effects of metformin and phenformin on apoptosis and epithelial-mesenchymal transition in chemoresistant rectal cancer" 110 : 2834-2845, 2019

24 Luo ZP, "Effects of LncRNA KCNQ1OT1 on proliferation and migration of ovarian cancer cells by Wnt/beta-catenin" 23 : 8788-8794, 2019

25 Sun H, "Dysregulation of KCNQ1OT1 promotes cholangiocarcinoma progression via miR140-5p/SOX4 axis" 658 : 7-15, 2018

26 Faivre-Finn C, "Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer(CONVERT) : an open-label, phase 3, randomised, superiority trial" 18 : 1116-1125, 2017

27 Wolin SL, "Cellular RNA surveillance in health and disease" 366 : 822-827, 2019

28 Fujita K, "Cancer therapy due to apoptosis : galectin-9" 18 : 74-, 2017

29 Ferlay J, "Cancer incidence and mortality worldwide : sources, methods and major patterns in GLOBOCAN 2012" 136 : E359-86, 2015

30 Sun Y, "A long noncoding RNA HOTTIP expression is associated with disease progression and predicts outcome in small cell lung cancer patients" 16 : 162-, 2017